Baker McKenzie advised Allecra on the deal. Allecra Therapeutics completed a licensing agreement with Shanghai Haini Pharmaceutical Co., Ltd., part of the Yangtze River Pharmaceutical Group…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
